Human Studies
Digexin Clinical & Mechanistic Research
Digexin® has been evaluated in randomized, double-blind, placebo-controlled human trials as well as advanced ex vivo microbiome models. Together, these studies demonstrate measurable digestive outcomes alongside defined mechanistic pathways involving stress modulation, microbial fermentation, and gut-derived signaling.
Clinical Study 1
30-day randomized, placebo-controlled human trial showing improvements in bowel movement frequency, digestive comfort, and gastrointestinal symptom scores in adults with digestive irregularity.
Clinical Study 2
60-day randomized human trial demonstrating improvements in digestive symptoms alongside reductions in perceived stress and modulation of cortisol and serotonin biomarkers.
GLP-1 Study
21-day randomized, double-blind, placebo-controlled human clinical trial on GLP-1 users found positive changes in gastrointestinal comfort, including bowel movements, gas, and bloating.
ProDigest Study
Ex vivo human colon model demonstrating increased short-chain fatty acid production, including significant increases in butyrate, propionate, and acetate.
Human Studies
Digexin Clinical & Mechanistic Research
Digexin® has been evaluated in randomized, double-blind, placebo-controlled human trials as well as advanced ex vivo microbiome models. Together, these studies demonstrate measurable digestive outcomes alongside defined mechanistic pathways involving stress modulation, microbial fermentation, and gut-derived signaling.
Scientific Resources
Scientific Resources
Published human and laboratory research support the efficacy and safety of Digexin®. Request access to additional scientific resources - including white papers, product information sheets, and safety evaluations.
Submit your name and email below, and our team will provide the materials you need.
Thank you!
We'll be in touch soon with the scientific resources you requested.
Take Your Brand to the Next Level with Digexin!
Contact us to secure your competitive advantage!